Compare Gerdau S.A. Common Stock (GGB) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gerdau S.A. Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Gerdau S.A. Common Stock trades at $5.09 (market cap $9.16B), while Nuvation Bio Inc. Class A Common Stock trades at $5.01 (market cap $1.74B). The key difference: Gerdau S.A. Common Stock is far larger — about 5.3× Nuvation Bio Inc. Class A Common Stock's market cap, and Gerdau S.A. Common Stock pays a 3.67% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gerdau S.A. Common Stock for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| GGB | NUVB | |
|---|---|---|
Market Cap | $9.16B | $1.74B |
Volume | 16,238,936 | 9,289,619 |
Sector | Basic Materials | Health |
52-Week High | $5.17 | $9.54 |
52-Week Low | $3.15 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $11.10B | $1.33B |
Dividend Yield | 3.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gerdau S.A. Common Stock
Gerdau is a steel producer with operations across the Americas. It makes long steel, specialty steel, and other products for construction and industrial markets.
Read more on GGB →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
